Diligence memo · auto-generated · as of July 3, 2026
Alchemia Oncology Pty Ltd
Alchemia Oncology Pty Ltd looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Alchemia Oncology Pty Ltd operates in Biotechnology, based in EIGHT MILE PLAINS.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Alchemia Oncology Pty Ltd has raised $1.3M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $709K on 2011-12-21.
Most recent recorded round closed around 2011-12-21.
Valuation (modeled)modeled
Provath models Alchemia Oncology Pty Ltd at approximately $39M (range $378K–$444M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.00× the median modeled value of Pre-Seed Biotechnology companies in 2010–2012 (132 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 1 months.
Last raise 14.5 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 1.2× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 22% of Biotechnology peers (4293 compared).
Modeled value ranks above 40% of those peers.
Closest niche peers: Hygeia Therapeutics, Inc., Act Biotech Inc, Ikonopedia, LLC, Iquum Inc, Koronis Pharma, Inc..
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.